IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orzalesi, N.
Right arrow Articles by Autelitano, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orzalesi, N.
Right arrow Articles by Autelitano, A.
(Investigative Ophthalmology and Visual Science. 2000;41:2566-2573.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Effect of Timolol, Latanoprost, and Dorzolamide on Circadian IOP in Glaucoma or Ocular Hypertension

Nicola Orzalesi, Luca Rossetti, Tommaso Invernizzi, Andrea Bottoli and Alessandro Autelitano

From the Eye Clinic, Institute of Biomedical Sciences, San Paolo Hospital, University of Milan, Italy.

PURPOSE. To compare the around-the-clock intraocular pressure (IOP) reduction induced by timolol 0.5%, latanoprost 0.005%, and dorzolamide in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT).

METHODS. In this crossover trial, 20 patients with POAG (n = 10) or OHT (n = 10) were treated with timolol, latanoprost, and dorzolamide for 1 month. The treatment sequence was randomized. All patients underwent measurements for four 24-hour tonometric curves: at baseline and after each 1-month period of treatment. The patients were admitted to the hospital, and IOP was measured by two well-trained evaluators masked to treatment assignment. Measurements were taken at 3, 6, and 9 AM and noon and at 3, 6, and 9 PM and midnight by handheld electronic tonometer (TonoPen XL; Bio-Rad, Glendale, CA) with the patient supine and sitting, and a Goldmann applanation tonometer (Haag-Streit, Bern, Switzerland) with the patient sitting at the slit lamp. Systemic blood pressure was recorded at the same times. The between-group differences were tested for significance by means of parametric analysis of variance. The circadian IOP curve of a small group of untreated healthy young subjects was also recorded using the same procedures. To compare the circadian IOP rhythms in the POAG-OHT and control groups, the acrophases for each subject were calculated.

RESULTS. When Goldmann sitting values were considered, all the drugs significantly reduced IOP in comparison with baseline at all times, except for timolol at 3 AM. Latanoprost was more effective in lowering IOP than timolol at 3, 6, and 9 AM (P = 0.03), noon (P = 0.01), 9 PM, and midnight (P = 0.05) and was more effective than dorzolamide at 9 AM, noon (P = 0.03), and 3 and 6 PM (P = 0.04). Timolol was more effective than dorzolamide at 3 PM (P = 0.05), whereas dorzolamide performed better than timolol at midnight and 3 AM (P = 0.05). An ancillary finding of this study was that in the group of healthy subjects, the pattern of IOP curve was different that in patients with eye disease.

CONCLUSIONS. Latanoprost seemed to lead to a fairly uniform circadian reduction in IOP, whereas timolol seemed to be less effective during the nighttime hours. Dorzolamide was less effective than latanoprost but led to a significant reduction in nocturnal IOP. The reason for the difference in the pattern of the IOP curve of healthy subjects is currently unknown and deserves further investigation.




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
K Mansouri, S Orguel, A Mermoud, I Haefliger, J Flammer, E Ravinet, and T Shaarawy
Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial
Br. J. Ophthalmol., March 1, 2008; 92(3): 332 - 336.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. G. Crowston, C. A. Morris, J. D. Lindsey, and R. N. Weinreb
Prostaglandin FP Receptors Do Not Contribute to 24-hour Intraocular Pressure Variation in Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2095 - 2098.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Quaranta, F. Gandolfo, R. Turano, F. Rovida, T. Pizzolante, A. Musig, and E. Gandolfo
Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2917 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
Y. Barkana, S. Anis, J. Liebmann, C. Tello, and R. Ritch
Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma.
Arch Ophthalmol, June 1, 2006; 124(6): 793 - 797.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
T. Hara, T. Hara, and T. Tsuru
Increase of peak intraocular pressure during sleep in reproduced diurnal changes by posture.
Arch Ophthalmol, February 1, 2006; 124(2): 165 - 168.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. N. Weinreb and J. H. K. Liu
Nocturnal rhythms of intraocular pressure.
Arch Ophthalmol, February 1, 2006; 124(2): 269 - 270.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
P Fogagnolo, L Rossetti, F Mazzolani, and N Orzalesi
Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma
Br. J. Ophthalmol., January 1, 2006; 90(1): 24 - 28.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. V. Bui, B. Edmunds, G. A. Cioffi, and B. Fortune
The Gradient of Retinal Functional Changes during Acute Intraocular Pressure Elevation
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 202 - 213.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
E D Sharpe, D G Day, C J Beischel, J S Rhodes, J A Stewart, and W C Stewart
Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension
Br. J. Ophthalmol., July 1, 2004; 88(7): 953 - 956.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. Sihota, R. Saxena, H. C. Agarwal, and V. Gulati
Crossover Comparison of Timolol and Latanoprost in Chronic Primary Angle-closure Glaucoma
Arch Ophthalmol, February 1, 2004; 122(2): 185 - 189.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. H. K. Liu, R. P. Bouligny, D. F. Kripke, and R. N. Weinreb
Nocturnal Elevation of Intraocular Pressure Is Detectable in the Sitting Position
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4439 - 4442.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. H. K. Liu, X. Zhang, D. F. Kripke, and R. N. Weinreb
Twenty-four-Hour Intraocular Pressure Pattern Associated with Early Glaucomatous Changes
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1586 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
N. Orzalesi, L. Rossetti, A. Bottoli, E. Fumagalli, and P. Fogagnolo
The Effect of Latanoprost, Brimonidine, and a Fixed Combination of Timolol and Dorzolamide on Circadian Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension
Arch Ophthalmol, April 1, 2003; 121(4): 453 - 457.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. H. K. Liu, D. F. Kripke, M. D. Twa, P. A. Gokhale, E. I. Jones, E.-H. Park, J. E. Meehan, and R. N. Weinreb
Twenty-Four-Hour Pattern of Intraocular Pressure in Young Adults with Moderate to Severe Myopia
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2351 - 2355.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology